Accendra Health, Inc.
ACH
$2.04
$0.084.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 708.97M | 697.26M | 681.92M | 673.88M | 695.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 708.97M | 697.26M | 681.92M | 673.88M | 695.02M |
| Cost of Revenue | 385.71M | 375.07M | 357.32M | 354.64M | 362.03M |
| Gross Profit | 323.26M | 322.20M | 324.60M | 319.24M | 332.99M |
| SG&A Expenses | 273.20M | 265.84M | 267.85M | 262.37M | 271.61M |
| Depreciation & Amortization | 29.23M | -- | 7.52M | 7.86M | 6.94M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 688.13M | 640.91M | 632.69M | 624.87M | 640.59M |
| Operating Income | 20.83M | 56.36M | 49.23M | 49.02M | 54.44M |
| Income Before Tax | -7.97M | -3.64M | -84.95M | -5.40M | -302.04M |
| Income Tax Expenses | 1.47M | 1.97M | -1.13M | -1.59M | 29.82M |
| Earnings from Continuing Operations | -9.44M | -5.61M | -83.82M | -3.81M | -331.86M |
| Earnings from Discontinued Operations | -46.88M | -144.67M | -785.24M | -21.17M | 35.74M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.33M | -150.28M | -869.06M | -24.98M | -296.12M |
| EBIT | 20.83M | 56.36M | 49.23M | 49.02M | 54.44M |
| EBITDA | 50.71M | 120.46M | 108.63M | 110.17M | 36.13M |
| EPS Basic | -0.73 | -1.94 | -11.30 | -0.32 | -3.86 |
| Normalized Basic EPS | -0.05 | 0.21 | 0.03 | 0.19 | 0.23 |
| EPS Diluted | -0.74 | -1.94 | -11.30 | -0.33 | -3.85 |
| Normalized Diluted EPS | -0.05 | 0.21 | 0.03 | 0.19 | 0.23 |
| Average Basic Shares Outstanding | 76.70M | 77.29M | 76.94M | 77.27M | 76.74M |
| Average Diluted Shares Outstanding | 76.70M | 77.29M | 76.94M | 77.27M | 76.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |